Proximagen Group plc

While over 270 companies are doing artificial intelligence-driven drug development, many potential partners and investors are holding out for the first fruits of AI-based approaches. However, Benevol

The US Food and Drug Administration has a dozen user fee goal dates for pending applications coming up in June, according to the Pink Sheet’s US FDA Performance Tracker. The majority of the applicatio

Industry channeled its inner Scott Gottlieb during the outgoing commissioner's final week as head of the agency by unleashing a barrage of drug development announcements. Here's your news in brief: P

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in